Related Experiment Video
Updated: May 22, 2025
09:18
A Sensitive Method to Quantify Senescent Cancer Cells
Published on: August 2, 2013
20.6K
Current Methodologies to Assess Cellular Senescence in Cancer
Panayiotis Laouris1, Daniel Muñoz-Espín2,3
1Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.
Methods in Molecular Biology (Clifton, N.J.)
|March 14, 2025
Summary
Cellular senescence, a state of stable cell-cycle arrest, has a dual role in cancer. Therapies targeting senescent cells show promise, but reliable biomarkers are still needed.
Area of Science:
- Oncology
- Cell Biology
- Aging Research
Background:
- Cellular senescence is a key factor in cancer development, acting as both a tumor suppressor and promoter.
- Senescent cells exhibit cell-cycle arrest and a senescence-associated secretory phenotype (SASP), influencing the tumor microenvironment.
- Hallmarks include cell-cycle arrest, inflammatory factor secretion, structural changes, and metabolic alterations.
Purpose of the Study:
- To explore the multifaceted role of cellular senescence in cancer.
- To review methods for studying senescence in preclinical models.
- To discuss emerging therapeutic strategies and the challenge of biomarker identification.
Main Methods:
- In vitro assays to study senescence.
- Ex vivo tissue analysis for senescent cell detection.
- In vivo detection techniques in preclinical models.
Main Results:
- Senescence can initially suppress tumors but may later promote cancer progression.
- The senescence-associated secretory phenotype (SASP) significantly impacts the tumor microenvironment.
- Senolytic and senomorphic therapies are emerging strategies for cancer treatment.
Conclusions:
- Cellular senescence presents a complex role in cancer, with potential for therapeutic exploitation.
- Developing reliable, universal biomarkers for senescence detection remains a significant challenge.
- A multimarker approach is necessary for accurate senescence characterization in diverse cancer contexts.
